At this time, posts about Celltrion Healthcare are surging on portals and stock communities. Today, foreigners have net sold 9,000 shares of Celltrion Healthcare, and institutions have net sold 7,000 shares, according to preliminary data. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.


As of 12:30 PM on the 15th, the stock price of Celltrion Healthcare is 155,700 KRW, down 3.41% from the previous day, with a trading volume of 3,545,282 shares, which is 43.28% of the 5-day average trading volume.


In addition to Celltrion Healthcare, posts by investors are also surging for Hanil Jinkong (123840), Utech (178780), and Etron (096040).



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing